Table 1.

Clinical studies that used ROAST to model individual heads under different research contexts.

Applications	Number of Subjects Modeled (References)	Use Purposes
Aging effects	N = 587 [22]	(I), (III)
	N = 130 [23]	(I), (II), (V)
	N = 54 [24]	(I), (II), (III)
Alzheimer/Dementia	N = 2 [25]	(II), (III)
	N = 60 [26]	(II), (III), (VI)
Brain tumor/lesion	N = 2 [27]	(I), (II)
	N = 2 [28]	(II), (VI)
	N = 8 [29]	(I), (II), (VI)
Cerebellar stimulation	N = 4 [30]	(I), (II), (VI)
	N = 12 [31]	(I), (II), (VI)
	N = 18 [32]	(I), (III), (IV)
	N = 10 [33]	(I), (III), (IV)
	N = 12 [34]	(I), (III), (IV)
	N = 25 [35]	(I), (III), (IV)
Cognition	N = 16 [36]	(I), (II), (VI)
Depression	N = 151 [37]	(I)
Epilepsy	N = 2 [38]	(I)
	N = 12 [39]	(I), (II), (VI)
Functional connectivity	N = 10 [40]	(I), (II)
Inter-individual variability	N = 57 [41]	(I), (II), (IV), (V) (VI)
	N = 50 [42]	(I), (II), (V), (VI)
	N = 14 [43]	(I), (II), (VI)
	N = 2 [44]	(I), (IV)
	N = 32 [45]	(II)
	N = 47 [46]	(I)
	N = 60 [47]	(I)
	N = 240 [48]	(I), (II), (III), (VI)
	N = 29 [49]	(I), (V)
	N = 47 [50]	(I), (V)
	N = 15 [51]	(II), (VI)
	N = 90 [52]	(II), (V), (VI)
Schizophrenia	N = 21 [53]	(I), (II), (VI)
	N = 17 [54]	(I)
Substance use disorder	N = 5 [55,56]	(II), (IV), (V), (VI)
Working memory and attention	N = 15 [57]	(I), (II)
Total	N = 1858

Use purposes include: (I) ROI analysis of E-field against clinical outcomes; (II) Visualization of the E-field at ROI; (III) Voxel-based morphometry; (IV) Optimization of the stimulation; (V) Dose control; (VI) Visualization of electrode placement.